BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shehta A, Han HS, Ahn S, Yoon YS, Cho JY, Choi YR. Post-resection recurrence of hepatocellular carcinoma in cirrhotic patients: Is thrombocytopenia a risk factor for recurrence? Surg Oncol 2016;25:364-9. [PMID: 27916167 DOI: 10.1016/j.suronc.2016.08.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Blüthner E, Bednarsch J, Malinowski M, Binder P, Pratschke J, Stockmann M, Kaffarnik M. Dynamic liver function is an independent predictor of recurrence-free survival after curative liver resection for HCC - A retrospective cohort study. International Journal of Surgery 2019;71:56-65. [DOI: 10.1016/j.ijsu.2019.08.033] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
2 Shu B, Wang S, Deng Y, Zhai M, Liu S. Intra-platelet serotonin in prognosis of tumorigenesis: Friend or foe? J Hepatol 2018;68:1333-4. [PMID: 29550342 DOI: 10.1016/j.jhep.2018.02.030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Aryal B, Shimizu T, Kadono J, Furoi A, Komokata T, Kitazono I, Koriyama C, Yamakuchi M, Hashiguchi T, Imoto Y. Post-Resection Exhaustion of Intra-Platelet Serotonin: Also an Indicator of Early Hepatocellular Carcinoma Recurrence? J Cancer 2017;8:3984-91. [PMID: 29187873 DOI: 10.7150/jca.20971] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
4 Wen L, Weng S, Yan C, Ye R, Zhu Y, Zhou L, Gao L, Li Y. A Radiomics Nomogram for Preoperative Prediction of Early Recurrence of Small Hepatocellular Carcinoma After Surgical Resection or Radiofrequency Ablation. Front Oncol 2021;11:657039. [PMID: 34026632 DOI: 10.3389/fonc.2021.657039] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Lin J, Chi MH, Zhang X, Weng SG. Correlation of postoperative splenic volume increase with prognosis of hepatocellular carcinoma after curative hepatectomy. Can J Surg 2019;62:418-25. [PMID: 31782297 DOI: 10.1503/cjs.015918] [Reference Citation Analysis]
6 Huang CY, Chang YJ, Wei PL, Hung CS, Wang W. Methyl gallate, gallic acid-derived compound, inhibit cell proliferation through increasing ROS production and apoptosis in hepatocellular carcinoma cells. PLoS One 2021;16:e0248521. [PMID: 33725002 DOI: 10.1371/journal.pone.0248521] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Hsiao YF, Cheng SB, Lai CY, Liu HT, Huang SC, Huang YC. The Prognostic Role of Glutathione and Its Related Antioxidant Enzymes in the Recurrence of Hepatocellular Carcinoma. Nutrients 2021;13:4071. [PMID: 34836325 DOI: 10.3390/nu13114071] [Reference Citation Analysis]
8 Aryal B, Yamakuchi M, Shimizu T, Kadono J, Furoi A, Gejima K, Komokata T, Hashiguchi T, Imoto Y. Deciphering Platelet Kinetics in Diagnostic and Prognostic Evaluation of Hepatocellular Carcinoma. Can J Gastroenterol Hepatol 2018;2018:9142672. [PMID: 30050894 DOI: 10.1155/2018/9142672] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
9 Luo HM, Zhao SZ, Li C, Chen LP. Preoperative platelet-albumin-bilirubin grades predict the prognosis of patients with hepatitis B virus-related hepatocellular carcinoma after liver resection: A retrospective study. Medicine (Baltimore). 2018;97:e0226. [PMID: 29561452 DOI: 10.1097/md.0000000000010226] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
10 Aryal B, Yamakuchi M, Shimizu T, Kadono J, Furoi A, Gejima K, Komokata T, Koriyama C, Hashiguchi T, Imoto Y. Predictive Value of Diminished Serum PDGF-BB after Curative Resection of Hepatocellular Cancer. J Oncol 2019;2019:1925315. [PMID: 30723501 DOI: 10.1155/2019/1925315] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
11 Aryal B, Yamakuchi M, Hashiguchi T, Imoto Y. Intra-platelet Serotonin as a Biomarker in HCC Recurrence: When Time Matters. J Cancer 2019;10:2384-5. [PMID: 31258742 DOI: 10.7150/jca.30696] [Reference Citation Analysis]